Mineralocorticoid Receptor

Mineralocorticoid Receptor Products

  • All (5)
  • Mineralocorticoid Receptor Inhibitor (1)
  • Mineralocorticoid Receptor Antagonists (4)
  • New Mineralocorticoid Receptor Products
Catalog No. Product Name Information Product Use Citations Product Validations
S1707 Eplerenone Eplerenone is a mineralocorticoid receptor antagonist, and blocks the action of aldosterone, used to control high blood pressure.
Oncol Rep, 2021, 46(3)202
BMJ Open Diabetes Res Care, 2020,
Int J Mol Sci, 2019, 20(4)
E1239 Apararenone Apararenone (MT-3995) is a selective, long-acting nonsteroidal mineralocorticoid receptors (MR) antagonist.
S5273 Canrenone Canrenone (Aldadiene, SC-9376, RP-11614, 6,7-Dehydro-7α-desthioacetylspironolactone), a cardiovascular drug, a sort of steroid, is spironolactone's major metabolite and has been widely used as a nonselective aldosterone receptor antagonist clinically to treat heart failure, high blood pressure, edema, liver ascites, and other cardiovascular diseases.
S9702 Finerenone Finerenone (FIN, BAY 94-8862) is a highly selective and orally available nonsteroidal antagonist of mineralocorticoid receptor (MR) with IC50 of 18 nM. Finerenone has the potential for cardiorenal diseases research, such as type 2 diabetes mellitus and chronic kidney disease.
E0704 Esaxerenone (CS-3150) Esaxerenone (CS-3150), a selective nonsteroidal mineralocorticoid receptor (MR) antagonist, binds to mineralocorticoid receptor and inhibits (3)H-aldosterone binding to mineralocorticoid receptor with an IC50 value of 9.4 nM. Esaxerenone (CS-3150) also has the property of increasing the likelihood of albuminuria returning to normal levels and reducing progression of albuminuria to higher levels.
E0704 Esaxerenone (CS-3150) Esaxerenone (CS-3150), a selective nonsteroidal mineralocorticoid receptor (MR) antagonist, binds to mineralocorticoid receptor and inhibits (3)H-aldosterone binding to mineralocorticoid receptor with an IC50 value of 9.4 nM. Esaxerenone (CS-3150) also has the property of increasing the likelihood of albuminuria returning to normal levels and reducing progression of albuminuria to higher levels.
S1707 Eplerenone Eplerenone is a mineralocorticoid receptor antagonist, and blocks the action of aldosterone, used to control high blood pressure.
Oncol Rep, 2021, 46(3)202
BMJ Open Diabetes Res Care, 2020,
Int J Mol Sci, 2019, 20(4)
E1239 Apararenone Apararenone (MT-3995) is a selective, long-acting nonsteroidal mineralocorticoid receptors (MR) antagonist.
S5273 Canrenone Canrenone (Aldadiene, SC-9376, RP-11614, 6,7-Dehydro-7α-desthioacetylspironolactone), a cardiovascular drug, a sort of steroid, is spironolactone's major metabolite and has been widely used as a nonselective aldosterone receptor antagonist clinically to treat heart failure, high blood pressure, edema, liver ascites, and other cardiovascular diseases.
S9702 Finerenone Finerenone (FIN, BAY 94-8862) is a highly selective and orally available nonsteroidal antagonist of mineralocorticoid receptor (MR) with IC50 of 18 nM. Finerenone has the potential for cardiorenal diseases research, such as type 2 diabetes mellitus and chronic kidney disease.

Choose Selective Mineralocorticoid Receptor Inhibitors

Tags: Mineralocorticoid Receptor inhibitor|Mineralocorticoid Receptor agonist|Mineralocorticoid Receptor activator|Mineralocorticoid Receptor inducer|Mineralocorticoid Receptor antagonist|Mineralocorticoid Receptor signaling pathway|Mineralocorticoid Receptor assay kit